Nilvadipine is a calcium channel blocker that is used to treat hypertension and angina. However, during the manufacturing process, impurities may be introduced into the drug, which can affect its efficacy and safety. These impurities can be organic or inorganic in nature and may arise from various sources such as starting materials, synthetic intermediates, or manufacturing equipment. Therefore, it is important to monitor and control the levels of Nilvadipine impurities to ensure the quality and safety of the drug product.